Table 2.
Associations of sarcopenia and its components with PEF and PEF%pred in the cross-sectional analysis
Model 1 | Model 2 | Model 3 | ||||
---|---|---|---|---|---|---|
β (95%CI) | P value | β (95%CI) | P value | β (95%CI) | P value | |
PEF | ||||||
HGS | 5.68 (5.34, 6.02) | < 0.001 | 3.58 (3.15, 4.01) | < 0.001 | 3.13 (2.68, 3.57) | < 0.001 |
Gait speed | 116.40 (101.10, 131.70) | < 0.001 | 68.51 (54.22, 82.80) | < 0.001 | 61.52 (47.25, 75.80) | < 0.001 |
5CST | − 5.85 (− 6.59, − 5.10) | < 0.001 | − 3.30 (− 4.00, − 2.59) | < 0.001 | − 3.07 (− 3.77, − 2.37) | < 0.001 |
SPPB | 19.06 (17.33, 20.79) | < 0.001 | 11.53 (9.81, 13.25) | < 0.001 | 10.66 (8.91, 12.40) | < 0.001 |
SMI | 42.27 (39.39, 45.16) | < 0.001 | 18.26 (13.77, 22.74) | < 0.001 | 69.65 (47.21, 92.08) | < 0.001 |
Sarcopenia | − 40.66 (− 47.33, − 33.99) | < 0.001 | − 26.74 (− 33.08, − 20.40) | < 0.001 | − 19.15 (− 26.69, − 11.62) | < 0.001 |
PEF%pred | ||||||
HGS | 0.65 (0.55, 0.74) | < 0.001 | 0.96 (0.84, 1.09) | < 0.001 | 0.84 (0.71, 0.97) | < 0.001 |
Gait speed | 18.29 (14.30, 22.28) | < 0.001 | 19.37 (15.27, 23.48) | < 0.001 | 17.51 (13.40, 21.62) | < 0.001 |
5CST | − 0.93 (− 1.12,− 0.73) | < 0.001 | − 1.00 (− 1.21, − 0.80) | < 0.001 | − 0.95 (− 1.15, − 0.75) | < 0.001 |
SPPB | 2.98 (2.52, 3.44) | < 0.001 | 3.46 (2.97, 3.96) | < 0.001 | 3.24 (2.74, 3.74) | < 0.001 |
SMI | 3.03 (2.22, 3.83) | < 0.001 | 5.24 (3.96, 6.53) | < 0.001 | 22.95 (16.50, 29.39) | < 0.001 |
Sarcopenia | − 6.36 (− 8.09, − 4.63) | < 0.001 | − 7.82 (− 9.64, − 6.00) | < 0.001 | − 5.82 (− 7.98, − 3.65) | < 0.001 |
HGS hand grip strength, 5CST five-repetition chair stand test, SPPB short physical performance battery, SMI skeletal muscle mass index, PEF peak expiratory flow
Model 1, unadjust
Model 2, adjust for age and sex
Model 3, adjust for age, sex, education level, smoking status, drinking status, BMI, marital status, residential area, type of cooking fuels, hypertension, diabetes, heart problems, stroke, and kidney disease